Chemistry:Pipamazine

From HandWiki
Short description: Chemical compound
Pipamazine
Chemical structure of Pipamazine
Clinical data
Pregnancy
category
Routes of
administration
Oral, intramuscular injection
ATC code
  • None
Legal status
Legal status
  • Withdrawn
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC21H24ClN3OS
Molar mass401.95 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Pipamazine (INN; trade names Mornidine, Mometine, Nausidol) is a drug of the phenothiazine class formerly used as an antiemetic. It is chemically related to chlorpromazine, but has negligible antipsychotic activity and produces few extrapyramidal side effects.[1]

Pipamazine was introduced to the U.S. market in 1959 by G. D. Searle & Company. It was advertised for morning sickness[2] and postoperative nausea and vomiting, and was claimed to reduce the need for postoperative analgesia.[3] It was eventually withdrawn from the U.S. market in 1969, after reports of hepatotoxicity (liver injury).[4][5]

There is very little published information on pipamazine; it is mostly absent from modern-day sources, apart from a few passing mentions in the pharmacological literature.[1]

Adverse effects

Mornidine advertisements for postoperative recovery claimed "unusually low side effects".[3] However, contemporary comparative trials found that hypotension (low blood pressure) was a substantial concern when the drug was given at normal dosages for this indication; blood pressure reductions of up to 70 mmHg were reported.[6] Reductions in dosage mitigated hypotension while maintaining antiemetic efficacy.

In his book The Creation of Psychopharmacology, Irish psychiatrist David Healy states that the failure of pipamazine to perform as a neuroleptic and its negative side effect profile helped Searle lose interest in the antipsychotic sector, and contributed to the company's refusal to market haloperidol in the United States.[7]

Synthesis

Thieme Patents:[8][9]

The alkylation of 2-chloro-10-(3-chloropropyl)phenothiazine [2765-59-5] (1) with Isonipecotamide [39546-32-2] (2) gives pipamazine (3).

References

  1. 1.0 1.1 (in Portuguese) Cinqüenta anos de medicamentos antipsicóticos em psiquiatria (1st ed.). Rio de Janeiro: UFRJ. 2003. pp. 486. ISBN 85-903827-1-0. http://www.medicina.ufrj.br/cursos/LH%20FROTA%20-%201%20Ed%20-%2050%20ANOS%20DE%20MEDICAMENTOS%20ANTIPSICOTICOS.pdf. Retrieved 2010-09-28. 
  2. [No authors listed] (July 1959). "Now she can cook breakfast again...". Canadian Medical Association Journal 81 (1): 59. PMC 1830735. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1830735/pdf/canmedaj00808-0002.pdf.  Advertisement.
  3. 3.0 3.1 [No authors listed] (April 1960). "Lessened postoperative vomiting with MORNIDINE". Annals of Surgery 151 (4). PMC 1613578. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1613578/pdf/annsurg01301-0002.pdf.  Advertisement.
  4. 34 FR 12051. July 17, 1969.
  5. "Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions". Archives of Internal Medicine 165 (12): 1363–9. June 2005. doi:10.1001/archinte.165.12.1363. PMID 15983284. 
  6. "Studies of anti-emetic drugs: A comparative study of cyclizine (Marzine), pipamazine (Mornidine), trimethobenzamide (Tigan), and hyoscine". Canadian Journal of Anesthesia 8 (2): 159–65. March 1961. doi:10.1007/BF03021345. 
  7. "Explorations in a new world". The creation of psychopharmacology. Cambridge: Harvard University Press. 2002. pp. 123–4. ISBN 0-674-01599-1. 
  8. John W Cusic, Dr Henry William Sause, DE patent 1089386 (1960 to Searle & Co).
  9. John W Cusic, Sause Henry William, U.S. Patent 2,957,870 (1960 to Searle & Co).